Background: The introduction of HAART has decreased mortality and progression to AIDS in perinatally HIV-1-infected children, but information on modification of the rate of specific clinical events is limited. Method: An observational population study on changes in HIV-1-related morbidity was conducted on 1402 perinatally HIV-1-infected children enrolled in the Italian Register for HIV Infection in Children and prospectively followed in the pre-HAART (1985-1995) and post-HAART periods (1996-2000, and 2001 -2005). Of this group, 773 children (55.1%) were followed from birth. Median observation time was 8.58 years (interquartile range, 3.71-13.72). Results: Overall, 666 (47.5%) children developed AIDS and 420 (29.9%) died. improved survival over time was evidenced at Kaplan-Meier analysis (P < 0.0001). Poisson regression analysis indicated that Centers for Disease Control and Prevention class B and C clinical event rates and most of the HIV-1-related organ complication rates significantly decreased starting from 1996-2000. Significant reductions in rates of cancer and opportunistic infections were evidenced after 2000. Nevertheless, opportunistic infections still occurred at high rates (6.09/100 person-years) in 2001-2005, with high rate of bacterial infections (3.55/100 person-years), particularly pneumonia (1.66/100 person-years), in this period. CD4 cell percentage was > 15% in 58.5% children with pneumonia. Conclusions: Progressive reductions of both mortality and rates of class B and C clinical events, including organ complications, were evidenced in the HAART era. Nevertheless, severe bacterial infections, particularly pneumonia, still occurred at considerable high rates, even in the absence of a severe CD4 cell depletion. (c) 2007 Lippincott Williams & Wilkins.

Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. The Italian Register for HIV Infection in Children

CONSOLINI, RITA;LEGITIMO, ANNALISA;
2007-01-01

Abstract

Background: The introduction of HAART has decreased mortality and progression to AIDS in perinatally HIV-1-infected children, but information on modification of the rate of specific clinical events is limited. Method: An observational population study on changes in HIV-1-related morbidity was conducted on 1402 perinatally HIV-1-infected children enrolled in the Italian Register for HIV Infection in Children and prospectively followed in the pre-HAART (1985-1995) and post-HAART periods (1996-2000, and 2001 -2005). Of this group, 773 children (55.1%) were followed from birth. Median observation time was 8.58 years (interquartile range, 3.71-13.72). Results: Overall, 666 (47.5%) children developed AIDS and 420 (29.9%) died. improved survival over time was evidenced at Kaplan-Meier analysis (P < 0.0001). Poisson regression analysis indicated that Centers for Disease Control and Prevention class B and C clinical event rates and most of the HIV-1-related organ complication rates significantly decreased starting from 1996-2000. Significant reductions in rates of cancer and opportunistic infections were evidenced after 2000. Nevertheless, opportunistic infections still occurred at high rates (6.09/100 person-years) in 2001-2005, with high rate of bacterial infections (3.55/100 person-years), particularly pneumonia (1.66/100 person-years), in this period. CD4 cell percentage was > 15% in 58.5% children with pneumonia. Conclusions: Progressive reductions of both mortality and rates of class B and C clinical events, including organ complications, were evidenced in the HAART era. Nevertheless, severe bacterial infections, particularly pneumonia, still occurred at considerable high rates, even in the absence of a severe CD4 cell depletion. (c) 2007 Lippincott Williams & Wilkins.
2007
WRITING COMMITTEE CHIAPPINI, E; Galli, L; Tovo, Pa; Gabiano, C; Lisi, C; Gattinara, Gc; Esposito, S; Viganò, A; Giaquinto, C; Rosso, R; Guarino, A; DE MARTINO M. MEMBERS OF THE ITALIAN REGISTER FOR HIV INFECTION IN CHILDREN P., Osimani; R., Cordiali; D., DE MATTIA; M., Manzionna; C., DI BARI; M., Ruggeri; M., Masi; A., Miniaci; F., Specchia; M., Ciccia; M., Lanari; F., Baldi; L., Battisti; R., Schumacher; M., Duse; M., Sinelli; V., Bennato; C., Dessì; M., Dedoni; M. L., Fenu; R., Cavallini; E., Anastasio; D., Zicchinella; M., Sticca; G., Pomero; R., Contiero; E., Fiumana; P., Gervaso; G., Gabrielli; G., Braccesi; S., Becherucci; M., DE GAUDIO; L., Innocenti; M. T., Cecchi; F., Ginocchio; L. A., Nicolini; B. W., Ciravegna; D., Cosso; A., Timitilli; M., Stronati; A., Plebani; J., Bojanin; A., Porta; N., Principi; V., Giacomet; R., Bianchi; G. V., Zuccotti; M., Giovannini; G., Ferraris; R., Lipreri; C., MORETTI MILANO; M., Cellini; M. C., Cano; G., Palazzi; E., Bruzzese; A., Giannattazio; L., Tarallo; F., Tancredi; R., D'Elia; O., Rampon; E. R., DALLE NOGARE; A., Sanfilippo; A., Romano; M., Saitta; I., Dodi; A., Barone; Consolini, Rita; Legitimo, Annalisa; C., Magnani; P., Falconieri; C., Fundarò; P. VALENTINI S., Salvucci; A. M., Casadei; S., Bernardi; P., Palma; M., Anzidei; S., Cerilli; C., Ajassa; A., Ganau; L., Cristiano; A., Mazza; L., Gentilini; F., Mignone; A., Versace; E., Antonielli; S., Sovatzis; C., Scolfaro; E., Palomba; V., Portelli; M., Rabusin; A., Pellegatta; P., Fortunati
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/117192
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 46
social impact